Skip to main content

Table 2 Characteristics of 3 study groups

From: Comparison of perceptions of obesity among adults with central obesity with and without additional cardiometabolic risk factors and among those who were formally obese, 3 years after screening for central obesity

  

Baseline

3 year follow-up

  

Persistent cardiometabolic risk group (n = 80)

Persistent obesity group (n = 63)

Improved cardiometabolic risk group (n = 49)

Persistent cardiometabolic risk group (n = 80)

Persistent obesity group (n = 63)

Improved cardiometabolic risk group (n = 49)

Gender (% male)

 

52.5

11.1***

65.3

   

Ethnicity (% Western European)

 

95.0

98.4

100.0

   

Higher education level (%)

 

28.7

27.0

30.6

   

Age (years)

 

49.4 (9.6)

45.5 (9.2)

49.7 (10.9)

52.8 (10.0)

48.9 (9.2)**

53.2 (10.8)

BMI (kg/m2)

 

31.0 (3.6)

28.8 (3.3)

28.4 (2.1)

30.7 (3.7)

29.3 (3.4)**

25.9 (2.5)***

Waist circumference (cm)

Men

112.8 (10)

106.5 (4)

105.5 (5)

109.3 (12.2)

109.1 (5.3)

99.1 (3.8)***

 

Women

101.8 (10)

95.3 (8)

92.0 (14)

98.9 (8.8)

95.2 (8.8)

82.0 (14.8)***

Blood pressure (mmHg)

Systolic

145.9 (17.3)

119.9 (5.9)

145.8 (13.5)

137.9 (14.8)

122.3 (8.4)***

133.6 (10.9)

 

Diastolic

89.6 (7.6)

75.5 (4.7)

88.4 (7.6)

83.9 (7.2)

75.6 (5.5)***

80.9 (7.9)

Triglycerides (mmol/L)

 

1.8 (6)

0.9 (0)

1.9 (1)

2.1 (0.9)

1.2 (0.5)***

1.5 (1.0)***

HDL cholesterol (mmol/L)

Men

1.0 (0.4)

1.3 (0.4)

1.5 (0.7)

1.1 (0.4)

1.2 (0.4)

1.2 (0.5)

 

Women

1.2 (0.3)

1.6 (0.5)

1.5 (0.6)

1.2 (0.2)

1.5 (0.5)***

1.4 (0.6)**

Fasting glucose (mmol/L)

 

5.2 (1.2)

4.8 (0.5)

4.9 (0.9)

5.5 (1.1)

5.0 (0.5)***

5.0 (0.8)**

  1. Data are reported as mean (standard deviation) for age, BMI and blood pressure, as median (inter quartile range) for waist circumference, triglycerides, HDL cholesterol and fasting glucose or percentage
  2. P-value for difference at 3 year follow-up between persistent cardiometabolic risk and persistent obesity groups: * p < 0.05; ** p < 0.01; *** p < 0.001
  3. P-value for difference at 3 year follow-up between persistent and improved cardiometabolic risk groups: * p < 0.05; ** p < 0.01; *** p < 0.001
  4. BMI body mass index, HDL cholesterol high-density lipoprotein cholesterol